Certain A Shares of Shanghai OPM Biosciences Co., Ltd. are subject to a Lock-Up Agreement Ending on 25-AUG-2023. These A Shares will be under lockup for 365 days starting from 25-AUG-2022 to 25-AUG-2023.

Details:
Xiao Zhihua, the controlling shareholder and actual controller, promised Within 36 months since the date of listing of the present shares, there will not be no transfers nor entrustment of shares to any third party nor repurchase by the Company. If, within 6 months after the issuer's listing, the closing price of the shares is lower than issuance price for 20 consecutive trading days or if trading price is lower than issuance price after 6 months from listing, lock-up period will be automatically extended for another 6 months. After the expiry of the lock-up period (including the extended lock-up period), during the time serves as the company director, supervisor and senior manager, the party promise that yearly transfer of shares made by him/her will not exceed 25% of the holding.

The actual controller He Yunfen promised Within 36 months since the date of listing of the present shares, there will not be no transfers nor entrustment of shares to any third party nor repurchase by the Company. If, within 6 months after the issuer's listing, the closing price of the shares is lower than issuance price for 20 consecutive trading days or if trading price is lower than issuance price after 6 month from listing, lock-up period will be automatically extended for another 6 months.

The controlling shareholder and the actual controller?s acting in concert, the shareholder Changzhou Wenshi Enterprise Management Consulting Partnership (Limited Partnership) Committed Within 36 months since the date of listing of the present shares, there will not be no transfers nor entrustment of shares to any third party nor repurchase by the Company. If, within 6 months after the issuer's listing, the closing price of the shares is lower than issuance price for 20 consecutive trading days or if trading price is lower than issuance price after 6 month from listing, lock-up period will be automatically extended for another 6 months.

Shareholder Huajie (Tianjin) Medical Investment Partnership (Limited Partnership), Guoshou Chengda (Shanghai) Health Industry Equity Investment Center (Limited Partnership), Shenzhen Dachen Chuanglian Equity Investment Fund Partnership (Limited Partnership), Beijing Yuanqing Bencao Equity Investment Center (Limited Partnership), Shenzhen Lingrui Cornerstone Equity Investment Fund Partnership (Limited Partnership), Shanghai Wen?ao Management Partnership (Limited Partnership), Ningbo Hehe Investment Management Partnership (Limited Partnership) promised Within 12 months since the date of listing of the present shares, there will not be no transfers nor entrustment of shares to any third party nor repurchase by the Company.

The shareholders Tibet Dingtai Enterprise Management Co., Ltd. and Shanghai Youliang Technology Center (Limited Partnership) promised After the company?s IPO passing the review of the Shanghai Stock Exchange and the approval of the China Securities Regulatory Commission for issuance and registration, since the date that the latest shares they obtained to 36 months, there will not be no transfers nor entrustment of shares to any third party nor repurchase by the Company.

Shareholder Panxin (Shanghai) Investment Center (Limited Partnership) promised After the company?s IPO passing the review of the Shanghai Stock Exchange and the approval of the China Securities Regulatory Commission for issuance and registration, for the shares they obtained 12 months before that date, there will not be no transfers nor entrustment of shares to any third party nor repurchase by the Company within 36 months.

Within 12 months since the date of listing of the present shares, there will not be no transfers nor entrustment of shares to any third party nor repurchase by the Company.